Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of REKVINA LABS. For more details, see the REKVINA LABS quarterly results and REKVINA LABS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.0 |
No. of shares | m | 6.03 |
1 Week | % | 0.0 |
1 Month | % | 0.0 |
1 Year | % | - |
52 week H/L | Rs | 4.6/3.6 |
No. of Mths Year Ending |
12 Mar-14* |
12 Mar-15* |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
5-Yr Chart Click to enlarge
|
---|
REKVINA LABS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 78 | 19 | 14 | 7 | 6 | |
Low | Rs | 6 | 8 | 4 | 4 | 5 | |
Sales per share (Unadj.) | Rs | 0.3 | 0.1 | 0.1 | 0 | 0 | |
Earnings per share (Unadj.) | Rs | 0.1 | 0 | -0.1 | 0 | -0.1 | |
Diluted earnings per share | Rs | 0.0 | 0.0 | -0.1 | -0.0 | -0.1 | |
Cash flow per share (Unadj.) | Rs | 0.1 | 0 | -0.1 | 0 | -0.1 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 2.3 | 0.9 | 0.8 | 0.8 | 0.7 | |
Adj. book value per share | Rs | 1.1 | 0.9 | 0.8 | 0.8 | 0.7 | |
Shares outstanding (eoy) | m | 3.01 | 6.03 | 6.03 | 6.03 | 6.03 | |
Price / Sales ratio | x | 162.3 | 243.1 | 90.6 | 0 | 0 | |
Avg P/E ratio | x | 560.9 | 1,990.0 | -100.6 | -176.6 | -39.9 | |
P/CF ratio (eoy) | x | 560.9 | 1,990.0 | -100.6 | -176.6 | -39.9 | |
Price / Book Value ratio | x | 18.5 | 14.2 | 11.3 | 7.0 | 7.8 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 126 | 80 | 57 | 34 | 32 | |
Total wages/salary | Rs m | 0 | 0 | 0 | 0 | 0 |
REKVINA LABS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1 | 0 | 1 | 0 | 0 | |
Other income | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total revenues | Rs m | 1 | 0 | 1 | 0 | 0 | |
Gross profit | Rs m | 0 | 0 | -1 | 0 | -1 | |
Depreciation | Rs m | 0 | 0 | 0 | 0 | 0 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit before tax | Rs m | 0 | 0 | -1 | 0 | -1 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | 0 | 0 | -1 | 0 | -1 | |
Gross profit margin | % | 35.8 | 15.3 | -89.7 | 0 | 0 | |
Effective tax rate | % | 19.3 | 18.2 | 0 | 0 | 0 | |
Net profit margin | % | 28.7 | 12.1 | -89.8 | 0 | 0 |
REKVINA LABS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 4 | 4 | 4 | 6 | 6 | |
Current liabilities | Rs m | 1 | 1 | 1 | 3 | 4 | |
Net working cap to sales | % | 415.3 | 993.6 | 430.7 | 0 | 0 | |
Current ratio | x | 4.6 | 4.3 | 3.0 | 1.8 | 1.4 | |
Inventory Days | Days | 409 | 967 | 506 | 0 | 0 | |
Debtors Days | Days | 1,043,633,269 | 2,770,936,212 | 1,607,809,937 | 0 | 0 | |
Net fixed assets | Rs m | 4 | 2 | 2 | 2 | 2 | |
Share capital | Rs m | 30 | 30 | 30 | 30 | 30 | |
"Free" reserves | Rs m | -23 | -25 | -25 | -25 | -26 | |
Net worth | Rs m | 7 | 6 | 5 | 5 | 4 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 8 | 7 | 6 | 8 | 8 | |
Interest coverage | x | 0 | 0 | 0 | 0 | 0 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.1 | 0.1 | 0.1 | 0 | 0 | |
Return on assets | % | 2.9 | 0.6 | -8.8 | -2.4 | -10.0 | |
Return on equity | % | 3.3 | 0.7 | -11.2 | -4.0 | -19.7 | |
Return on capital | % | 4.1 | 0.9 | -11.2 | -4.0 | -19.6 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
REKVINA LABS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -0 | -0 | -0 | 0 | -0 | |
From Investments | Rs m | 0 | 0 | 1 | -1 | 0 | |
From Financial Activity | Rs m | 0 | 0 | -0 | 2 | 0 | |
Net Cashflow | Rs m | 0 | 0 | 0 | 1 | 0 |
Share Holding
Shareholding as on Dec 2023
|
Company Information
|
YEAR OF INC: 1988 | BSE CODE: 526075 | FV (Rs): 5 | DIV YIELD (%): - |
More Trading Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare REKVINA LABS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.